Form 4: Core Scientific Director Jordan Levy Acquires 62,500 Shares of Common Stock

Director Jordan Levy purchased 62,500 shares of Core Scientific, Inc. common stock at a weighted average price of $8.0081 on March 6, 2025.

Summary

• On March 6, 2025, Jordan Levy, a director of Core Scientific, Inc., acquired 62,500 shares of common stock.
• The shares were purchased at a weighted average price of $8.0081 per share.
• The transactions occurred at prices ranging from $7.995 to $8.02.
• Following the transaction, Levy directly owns 306,887 shares of Core Scientific common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It reflects an insider's confidence in the company through stock acquisition, but it's a single transaction and doesn't provide a comprehensive view.

Industry Context

This Form 4 filing indicates insider activity, which is often monitored by investors for signals about a company's prospects. A director's purchase can be interpreted as a positive sign, reflecting confidence in the company's future performance.

Stakeholder Impact

• The purchase of shares by a director could positively influence shareholder sentiment.

Key Dates